Laboratory Safety: The Handbook. Global Edition

The international rollout of new molecular diagnostic tools (line probe assays and GeneXpert) now enables rapid identification of people with active TB disease, and concomitantly, resistance to rifampicin, a key proxy for MDR-TB. Culture and drug susceptibility testing (DST) are required, especially for patients at risk of having drug-resistant TB, and for monitoring their response to treatment.